Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€37.60
Target price
08.12.24
€66.97
Performance (%)
5.32%
Price
18:42
€36.80
Summary
This prediction is currently active. With a performance of 5.32%, the BUY prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 4.688% | 4.688% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $72.00 price target on the stock.
Ratings data for RARE provided by MarketBeat